| Primary |
| Blood Cholesterol Increased |
32.1% |
| Hypercholesterolaemia |
16.1% |
| Hypertension |
13.3% |
| Hyperlipidaemia |
6.1% |
| Diabetes Mellitus |
5.7% |
| Blood Cholesterol |
4.6% |
| Dyslipidaemia |
3.6% |
| Blood Cholesterol Abnormal |
3.5% |
| Cardiac Disorder |
1.8% |
| Angina Pectoris |
1.6% |
| Depression |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Blood Pressure |
1.3% |
| Pain |
1.2% |
| Myocardial Infarction |
1.2% |
| Coronary Artery Disease |
1.1% |
| Low Density Lipoprotein Increased |
1.1% |
| Blood Triglycerides Increased |
1.0% |
| Hypothyroidism |
0.9% |
| Blood Pressure Abnormal |
0.9% |
|
| Myalgia |
14.4% |
| Pain In Extremity |
12.9% |
| Rhabdomyolysis |
9.0% |
| Myocardial Infarction |
7.2% |
| Muscle Spasms |
6.0% |
| Pain |
5.8% |
| Malaise |
5.8% |
| Drug Dose Omission |
3.8% |
| Alopecia |
3.7% |
| Weight Decreased |
3.6% |
| Weight Increased |
3.6% |
| Cerebrovascular Accident |
3.4% |
| Vomiting |
3.0% |
| Blood Cholesterol Increased |
2.8% |
| Muscular Weakness |
2.8% |
| Nausea |
2.7% |
| Paraesthesia |
2.4% |
| High Density Lipoprotein Decreased |
2.4% |
| Renal Failure |
2.3% |
| Oedema Peripheral |
2.3% |
|
| Secondary |
| Blood Cholesterol Increased |
20.3% |
| Hypertension |
15.0% |
| Product Used For Unknown Indication |
9.3% |
| Hypercholesterolaemia |
8.4% |
| Diabetes Mellitus |
5.6% |
| Gastrooesophageal Reflux Disease |
5.1% |
| Blood Cholesterol Abnormal |
4.9% |
| Hyperlipidaemia |
4.2% |
| Drug Use For Unknown Indication |
4.0% |
| Blood Cholesterol |
2.6% |
| Cardiac Disorder |
2.6% |
| Depression |
2.4% |
| Dyslipidaemia |
2.2% |
| Type 2 Diabetes Mellitus |
2.1% |
| Blood Pressure Abnormal |
2.1% |
| Blood Triglycerides Increased |
2.1% |
| Anxiety |
1.9% |
| Pain |
1.9% |
| Asthma |
1.9% |
| Myocardial Infarction |
1.5% |
|
| Myalgia |
12.8% |
| Pain In Extremity |
10.5% |
| Malaise |
6.7% |
| Off Label Use |
6.6% |
| Myocardial Infarction |
5.9% |
| Weight Increased |
5.4% |
| Pain |
5.3% |
| Rhabdomyolysis |
5.2% |
| Muscle Spasms |
5.0% |
| Weight Decreased |
4.9% |
| Vomiting |
4.7% |
| Drug Dose Omission |
4.5% |
| Drug Ineffective |
3.9% |
| Intentional Drug Misuse |
3.7% |
| Cerebrovascular Accident |
2.6% |
| Nasopharyngitis |
2.5% |
| Wrong Technique In Drug Usage Process |
2.5% |
| Muscular Weakness |
2.4% |
| Diabetes Mellitus |
2.3% |
| Hypertension |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.7% |
| Drug Use For Unknown Indication |
11.1% |
| Hypertension |
10.6% |
| Blood Cholesterol Increased |
5.7% |
| Diabetes Mellitus |
4.4% |
| Rheumatoid Arthritis |
3.9% |
| Type 2 Diabetes Mellitus |
3.2% |
| Pain |
2.6% |
| Atrial Fibrillation |
2.5% |
| Depression |
2.3% |
| Osteoporosis |
2.0% |
| Prophylaxis |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Hyperlipidaemia |
1.8% |
| Blood Cholesterol |
1.6% |
| Cardiac Disorder |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Anxiety |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Asthma |
1.3% |
|
| Flushing |
12.9% |
| Weight Decreased |
9.4% |
| Vomiting |
8.9% |
| Pruritus |
7.1% |
| Weight Increased |
6.3% |
| Drug Ineffective |
6.1% |
| Nausea |
5.6% |
| Myocardial Infarction |
5.3% |
| Pain |
4.0% |
| Paraesthesia |
3.8% |
| Rash |
3.5% |
| Pain In Extremity |
3.4% |
| Dyspnoea |
3.2% |
| Renal Failure Acute |
3.1% |
| Urticaria |
3.0% |
| Tremor |
3.0% |
| Headache |
3.0% |
| Pneumonia |
2.9% |
| Vision Blurred |
2.8% |
| Fatigue |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
30.4% |
| Drug Use For Unknown Indication |
9.7% |
| Hypercholesterolaemia |
8.5% |
| Blood Cholesterol Increased |
6.6% |
| Dyslipidaemia |
5.9% |
| Diabetes Mellitus |
4.2% |
| Depression |
4.0% |
| Hypertension |
3.8% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Hyperlipidaemia |
3.1% |
| Atrial Fibrillation |
2.8% |
| Cardiac Disorder |
2.6% |
| Hiv Infection |
2.4% |
| Thrombosis Prophylaxis |
2.4% |
| Angina Pectoris |
2.1% |
| Blood Triglycerides Increased |
2.1% |
| Hiatus Hernia |
2.1% |
| Hyperuricaemia |
1.4% |
| Myocardial Infarction |
1.4% |
| Pain |
1.4% |
|
| Drug Interaction |
19.6% |
| Rhabdomyolysis |
14.4% |
| Myalgia |
11.3% |
| Fatigue |
5.2% |
| International Normalised Ratio Increased |
5.2% |
| Sleep Disorder |
4.1% |
| Syncope |
4.1% |
| Weight Decreased |
4.1% |
| Muscle Disorder |
3.1% |
| Off Label Use |
3.1% |
| Renal Failure |
3.1% |
| Renal Failure Acute |
3.1% |
| Renal Impairment |
3.1% |
| Vomiting |
3.1% |
| Wound |
3.1% |
| Gingival Bleeding |
2.1% |
| Hypotension |
2.1% |
| Liver Disorder |
2.1% |
| Low Density Lipoprotein Increased |
2.1% |
| Malaise |
2.1% |
|
